BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yamamoto K, Takada Y, Fujimoto Y, Haga H, Oike F, Kobayashi N, Tanaka K. Nonalcoholic steatohepatitis in donors for living donor liver transplantation. Transplantation. 2007;83:257-262. [PMID: 17297396 DOI: 10.1097/01.tp.0000250671.06456.3f] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Fujiyoshi M, Ozaki M. Molecular mechanisms of liver regeneration and protection for treatment of liver dysfunction and diseases. J Hepatobiliary Pancreat Sci. 2011;18:13-22. [PMID: 20607568 DOI: 10.1007/s00534-010-0304-2] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 7.1] [Reference Citation Analysis]
2 Irie R, Nakazawa A, Sakamoto S, Takeda M, Yanagi Y, Shimizu S, Uchida H, Fukuda A, Kasahara M. Outcome for Pediatric Recipients of Macrosteatotic Liver Grafts From Living Donors. Liver Transpl 2020;26:899-905. [PMID: 32314485 DOI: 10.1002/lt.25784] [Reference Citation Analysis]
3 Lo CM. Nonalcoholic steatohepatitis in donors for living donor liver transplantation. Transplantation. 2007;83:265-266. [PMID: 17297398 DOI: 10.1097/01.tp.0000250675.55779.dd] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
4 Eguchi Y, Hyogo H, Ono M, Mizuta T, Ono N, Fujimoto K, Chayama K, Saibara T;  JSG-NAFLD. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J Gastroenterol. 2012;47:586-595. [PMID: 22328022 DOI: 10.1007/s00535-012-0533-z] [Cited by in Crossref: 316] [Cited by in F6Publishing: 264] [Article Influence: 31.6] [Reference Citation Analysis]
5 Kumar R, Porwal YC, Dev N, Kumar P, Chakravarthy S, Kumawat A. Association of high-sensitivity C-reactive protein (hs-CRP) with non-alcoholic fatty liver disease (NAFLD) in Asian Indians: A cross-sectional study. J Family Med Prim Care 2020;9:390-4. [PMID: 32110624 DOI: 10.4103/jfmpc.jfmpc_887_19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
6 Mancero JMP, Gonzalez AM, Ribeiro MAF, Peron G, Wahle RC, Dazzi FL, de Oliveira e Silva A, D’albuquerque LAC. Living Donor Right Liver Lobe Transplantation With or Without Inclusion of the Middle Hepatic Vein: Analysis of Complications. World J Surg 2011;35:403-8. [DOI: 10.1007/s00268-010-0857-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
7 Drebber U, Torbenson M, Wedemeyer I, Dienes H. Aktuelle Aspekte zur Histopathologie im Rahmen der Lebertransplantation. Pathologe 2011;32:113-23. [DOI: 10.1007/s00292-010-1405-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
8 Ikegami T, Onda S, Furukawa K, Haruki K, Shirai Y, Gocho T. Small-for-size graft, small-for-size syndrome and inflow modulation in living donor liver transplantation. J Hepatobiliary Pancreat Sci 2020;27:799-809. [PMID: 32897590 DOI: 10.1002/jhbp.822] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Cheng Q, Ng KT, Fan ST, Lim ZX, Guo DY, Liu XB, Liu Y, Poon RT, Lo CM, Man K. Distinct mechanism of small-for-size fatty liver graft injury--Wnt4 signaling activates hepatic stellate cells. Am J Transplant 2010;10:1178-88. [PMID: 20420630 DOI: 10.1111/j.1600-6143.2010.03102.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
10 Pan JJ, Fallon MB. Gender and racial differences in nonalcoholic fatty liver disease. World J Hepatol 2014; 6(5): 274-283 [PMID: 24868321 DOI: 10.4254/wjh.v6.i5.274] [Cited by in Crossref: 177] [Cited by in F6Publishing: 166] [Article Influence: 22.1] [Reference Citation Analysis]
11 Chiu KW, Nakano T, Hu TH, Chen KD, Hsu LW, Eng HL, Cheng YF, Goto S, Chen CL. Association between Subclinical Low Serum 25(OH)D in Donors and Fatty Liver Disease in Recipients after Living Donor Liver Transplantation. Biomed Res Int 2018;2018:4508085. [PMID: 29750155 DOI: 10.1155/2018/4508085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Siriwardana RC, Sivasundaram T, Paranaheva L, Ediriweera DS. Computed tomography-based evaluation of segmental variation of liver density and its implications. Indian J Gastroenterol 2020;39:60-5. [PMID: 32152904 DOI: 10.1007/s12664-019-01008-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Lo C. Evaluating the living donor: expansion by innovation. Hepatol Int 2016;10:242-4. [DOI: 10.1007/s12072-016-9713-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
14 Verna EC, Loomba R. Editorial: Call to screen for NAFLD and NASH in psoriasis. Aliment Pharmacol Ther 2015;41:492-3. [PMID: 25631653 DOI: 10.1111/apt.13075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 Pamecha V, Patil NS, Parthasarathy K, Sinha PK, Mohapatra N, Rastogi A, Rudrakumar K, Mukund A, Chaudhary A, Kanal U. Expanding donor pool for live donor liver transplantation: utilization of donors with non-alcoholic steatohepatitis after optimization. Langenbecks Arch Surg 2022. [PMID: 35243535 DOI: 10.1007/s00423-022-02444-5] [Reference Citation Analysis]
16 Lo CM. Expanding living donor liver transplantation. Liver Transpl 2016;22:37-9. [PMID: 27574723 DOI: 10.1002/lt.24618] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
17 Armstrong MJ, Houlihan DD, Bentham L, Shaw JC, Cramb R, Olliff S, Gill PS, Neuberger JM, Lilford RJ, Newsome PN. Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort. J Hepatol 2012;56:234-40. [PMID: 21703178 DOI: 10.1016/j.jhep.2011.03.020] [Cited by in Crossref: 170] [Cited by in F6Publishing: 149] [Article Influence: 15.5] [Reference Citation Analysis]
18 Yeh H, Olthoff KM. Live donor adult liver transplantation. Curr Opin Organ Transplant 2008;13:241-6. [PMID: 18685310 DOI: 10.1097/MOT.0b013e328300a352] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Ozaki M. Cellular and molecular mechanisms of liver regeneration: Proliferation, growth, death and protection of hepatocytes. Semin Cell Dev Biol 2020;100:62-73. [PMID: 31669133 DOI: 10.1016/j.semcdb.2019.10.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
20 Farrell GC, Teoh NC, McCuskey RS. Hepatic microcirculation in fatty liver disease. Anat Rec (Hoboken). 2008;291:684-692. [PMID: 18484615 DOI: 10.1002/ar.20715] [Cited by in Crossref: 166] [Cited by in F6Publishing: 159] [Article Influence: 11.9] [Reference Citation Analysis]
21 Sayiner M, Koenig A, Henry L, Younossi ZM. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World. Clin Liver Dis. 2016;20:205-214. [PMID: 27063264 DOI: 10.1016/j.cld.2015.10.001] [Cited by in Crossref: 247] [Cited by in F6Publishing: 238] [Article Influence: 35.3] [Reference Citation Analysis]
22 Zezos P, Renner EL. Liver transplantation and non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(42): 15532-15538 [PMID: 25400437 DOI: 10.3748/wjg.v20.i42.15532] [Cited by in CrossRef: 106] [Cited by in F6Publishing: 92] [Article Influence: 13.3] [Reference Citation Analysis]
23 Ikegami T, Shimada M, Imura S, Arakawa Y, Nii A, Morine Y, Kanemura H. Current concept of small-for-size grafts in living donor liver transplantation. Surg Today. 2008;38:971-982. [PMID: 18958553 DOI: 10.1007/s00595-008-3771-1] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 4.2] [Reference Citation Analysis]
24 Tan L, Liu F, Liu ZL, Xiao JW. Meta-Analysis of Risk Factors for Bile Leakage After Hepatectomy Without Biliary Reconstruction. Front Surg 2021;8:764211. [PMID: 34790696 DOI: 10.3389/fsurg.2021.764211] [Reference Citation Analysis]
25 Duseja A, Chalasani N. Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD). Hepatol Int 2013;7 Suppl 2:755-64. [PMID: 26202291 DOI: 10.1007/s12072-013-9480-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
26 Klaric KA, Parai JL, Kepron CA, Walker AE, Milroy CM. Postmortem survey of haemoglobin A1c, non-alcoholic steatohepatitis and liver fibrosis within a general population. J Clin Pathol 2022:jclinpath-2021-207998. [PMID: 35534202 DOI: 10.1136/jclinpath-2021-207998] [Reference Citation Analysis]
27 Inoue Y, Suzuki Y, Yokohama K, Ohama H, Tsuchimoto Y, Asai A, Fukunishi S, Kimura F, Higuchi K, Uchiyama K. Diabetes mellitus does not influence results of hepatectomy in hepatocellular carcinoma: case control study. Contemp Oncol (Pozn) 2020;24:211-5. [PMID: 33531867 DOI: 10.5114/wo.2020.102825] [Reference Citation Analysis]
28 Samstein B, Klair T. Living Donor Liver Transplantation: Donor Selection and Living Donor Hepatectomy. Curr Surg Rep 2015;3. [DOI: 10.1007/s40137-015-0107-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
29 Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140:124-131. [PMID: 20858492 DOI: 10.1053/j.gastro.2010.09.038] [Cited by in Crossref: 1312] [Cited by in F6Publishing: 1217] [Article Influence: 109.3] [Reference Citation Analysis]
30 Sherif ZA, Saeed A, Ghavimi S, Nouraie SM, Laiyemo AO, Brim H, Ashktorab H. Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations. Dig Dis Sci. 2016;61:1214-1225. [PMID: 27038448 DOI: 10.1007/s10620-016-4143-0] [Cited by in Crossref: 98] [Cited by in F6Publishing: 92] [Article Influence: 16.3] [Reference Citation Analysis]
31 Schneier AT, Citti CC, Dieterich DT. Management and diagnosis of fatty liver disease. Expert Rev Gastroenterol Hepatol. 2015;9:671-683. [PMID: 25716275 DOI: 10.1586/17474124.2015.1003209] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
32 Mohamed MM, Daoud A, Quadri S, Casey MJ, Salas MAP, Rao V, Fülöp T, Soliman KM. Hypertension and obesity in living kidney donors. World J Transplant 2021; 11(6): 180-186 [PMID: 34164293 DOI: 10.5500/wjt.v11.i6.180] [Cited by in CrossRef: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Harmon RC, Tiniakos DG, Argo CK. Inflammation in nonalcoholic steatohepatitis. Expert Review of Gastroenterology & Hepatology 2014;5:189-200. [DOI: 10.1586/egh.11.21] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 7.0] [Reference Citation Analysis]
34 Liu LU, Schiano TD. Long-term care of the liver transplant recipient. Clin Liver Dis. 2007;11:397-416. [PMID: 17606214 DOI: 10.1016/j.cld.2007.04.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
35 Tanoue S, Uto H, Kumamoto R, Arima S, Hashimoto S, Nasu Y, Takami Y, Moriuchi A, Sakiyama T, Oketani M. Liver regeneration after partial hepatectomy in rat is more impaired in a steatotic liver induced by dietary fructose compared to dietary fat. Biochem Biophys Res Commun. 2011;407:163-168. [PMID: 21371432 DOI: 10.1016/j.bbrc.2011.02.131] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
36 Goto S, Nakano T, Chen C, Chiu K, Hsu L, I S. Application of Artificial Sunlight for the Elderly as a Possible Environmental Nursing Practice. POJ Nurs Prac Res 2018;2:1-5. [DOI: 10.32648/2577-9516/2/1/002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
37 Sakamoto S, Nosaka S, Shigeta T, Uchida H, Hamano I, Karaki C, Kanazawa H, Fukuda A, Nakazawa A, Kasahara M. Living donor liver transplantation using grafts with hepatic cysts. Liver Transpl 2012;18:1415-20. [DOI: 10.1002/lt.23546] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
38 Duell PB, Welty FK, Miller M, Chait A, Hammond G, Ahmad Z, Cohen DE, Horton JD, Pressman GS, Toth PP; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Hypertension; Council on the Kidney in Cardiovascular Disease; Council on Lifestyle and Cardiometabolic Health; and Council on Peripheral Vascular Disease. Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association. Arterioscler Thromb Vasc Biol 2022;42:e168-85. [PMID: 35418240 DOI: 10.1161/ATV.0000000000000153] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
39 Drebber U, Dienes H. Transplantationspathologie der Leber. Pathologe 2008;29:84-92. [DOI: 10.1007/s00292-007-0956-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
40 Tsochatzis EA, Papatheodoridis GV. Is there any progress in the treatment of non-alcoholic fatty liver disease? World J Gastrointest Pharmacol Ther 2011; 2(1): 1-5 [PMID: 21577310 DOI: 10.4292/wjgpt.v2.i1.1] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
41 Chaudhary A, Sood G, Kumar N, Chauhan C, Yadav DPS, Kasana V, Arora R, Gangwani G. Validation of Accuracy of Non-Invasive Imaging Methods (Magnetic Resonance Imaging (MRI) Fat Fraction Calculation and Computed Tomography (CT) Liver Attenuation Index) for Hepatic Graft Fat Quantification in Living Liver Transplant Donors. Ann Transplant 2021;26:e933801. [PMID: 34824190 DOI: 10.12659/AOT.933801] [Reference Citation Analysis]
42 Olthoff KM, Reddy KR. First, do no harm: The question of liver biopsy in living liver donors. Liver Transpl 2008;14:420-2. [DOI: 10.1002/lt.21478] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
43 Hertl M, Cosimi AB. Living donor liver transplantation: how can we better protect the donors? Transplantation 2007;83:263-4. [PMID: 17297397 DOI: 10.1097/01.tp.0000250676.71656.39] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
44 Tevar AD, Clarke C, Wang J, Rudich SM, Woodle ES, Lentsch AB, Edwards ML. Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantation. J Am Coll Surg. 2010;210:515-526. [PMID: 20347746 DOI: 10.1016/j.jamcollsurg.2010.01.020] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
45 Yoon JH, Lee JM, Suh KS, Lee KW, Yi NJ, Lee KB, Han JK, Choi BI. Combined Use of MR Fat Quantification and MR Elastography in Living Liver Donors: Can It Reduce the Need for Preoperative Liver Biopsy? Radiology 2015;276:453-64. [PMID: 25763828 DOI: 10.1148/radiol.15140908] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
46 Kasahara M, Sakamoto S, Fukuda A. Pediatric living-donor liver transplantation. Seminars in Pediatric Surgery 2017;26:224-32. [DOI: 10.1053/j.sempedsurg.2017.07.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]